camostat and 3-methylcholanthrene
camostat has been researched along with 3-methylcholanthrene in 4 studies
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Fujii, S; Ohkoshi, M | 3 |
Ohkoshi, M | 1 |
Other Studies
4 other study(ies) available for camostat and 3-methylcholanthrene
Article | Year |
---|---|
Effect of a protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on the growth of mouse skin carcinoma in the rapid growing stage.
Topics: Administration, Oral; Animals; Carcinoma, Squamous Cell; Cell Division; Esters; Female; Gabexate; Guanidines; Methylcholanthrene; Mice; Protease Inhibitors; Skin Neoplasms | 1984 |
Effect of the synthetic protease inhibitor [N,N-dimethylcarbamoyl-methyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on carcinogenesis by 3-methylcholanthrene in mouse skin.
Topics: Animals; Carcinoma, Squamous Cell; Diet; Esters; Female; Gabexate; Guanidines; Methylcholanthrene; Mice; Mice, Inbred Strains; Probability; Protease Inhibitors; Skin Neoplasms; Time Factors | 1983 |
Effect of oral administration of protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on the growth of 3-methylcholanthrene-induced carcinoma in mice.
Topics: Animals; Carcinoma, Squamous Cell; Cell Division; Esters; Female; Gabexate; Guanidines; Methylcholanthrene; Mice; Neoplasms, Experimental; Protease Inhibitors; Skin Neoplasms | 1982 |
Inhibition of growth of 3-methylcholanthrene-induced mouse skin tumor by protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate.
Topics: Animals; Body Weight; Carcinoma, Squamous Cell; Cell Division; Drug Evaluation, Preclinical; Esters; Female; Gabexate; Guanidines; Methylcholanthrene; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Protease Inhibitors; Skin Neoplasms | 1981 |